Evidence map›Paper›PMID 42362751›Full record

ArticleArchives of toxicology2026

Correction: The potent human CAR activator CITCO is a non-genotoxic hepatic tumour-promoting agent in humanised constitutive androstane receptor mice but not in wild-type animals.

C J Henderson, A W McLaren, A K MacLeod, D Lin, A R Cameron, L R Chatham, J Moggs, F Inesta-Vaquera, John P Thomson, Richard R Meehan and 3 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

C J HendersonDivision of Systems Medicine, Jacqui Wood Cancer Centre, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, DD1 9SY, UK.ORCID http://orcid.org/0000-0002-4764-639X
A W McLarenDivision of Systems Medicine, Jacqui Wood Cancer Centre, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, DD1 9SY, UK.
A K MacLeodDrug Discovery Unit, School of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK.
D LinDrug Discovery Unit, School of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK.
A R CameronSchool of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK.
L R ChathamCharles River, High Peak Business Park, Buxton Road, Chinley, SK23 6FJ, UK.
J MoggsNovartis BioMedical Research, Preclinical Safety, Translational Medicine, Basel, Switzerland.
F Inesta-VaqueraDivision of Systems Medicine, Jacqui Wood Cancer Centre, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, DD1 9SY, UK.
John P ThomsonNicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 1QY, UK.
Richard R MeehanMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Crewe Rd S, Edinburgh, EH4 1QY, UK.
P ChakravartyThe Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
M SchwarzDepartment of Experimental and Clinical Pharmacology and Pharmacogenomics, University of Tübingen, Wilhelmstraße 56, 72074, Tübingen, Germany.
C Roland WolfDivision of Systems Medicine, Jacqui Wood Cancer Centre, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, DD1 9SY, UK. c.r.wolf@dundee.ac.uk.ORCID http://orcid.org/0000-0002-6969-0113

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42362751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.